secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2024-08-05T23:59:59+00:00
Accession:  0000950170-24-090774
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q2 revenue $63.7M (+5% YoY); net loss $(306.2)M on $363.6M goodwill impairment
--------------------------------------------------------------------------------

- Revenue $63.7M (+5% YoY); net loss $(306.2)M including $363.6M goodwill impairment (up 2,538% from $(11.6)M).
- Adjusted EBITDA $20.9M (33% margin) vs $17.2M; Adjusted Net Income $14.2M vs $12.4M.
- Enterprise customers grew 6% YoY to 537; cash from ops $14.0M, unlevered FCF $21.5M.
- Q3 2024 guidance: revenue $61-62.5M; adj. EBITDA $17.5-19M. FY2024 revenue $247-251M; adj. EBITDA $74-77M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024090774/0000950170-24-090774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024090774/dh-20240805.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-090774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer